Acuity Acquires Rights to Eye Disease Anti-Infective
Posted on: Thursday, 20 April 2006, 15:00 CDT
Acuity Pharmaceuticals has acquired the exclusive worldwide rights to Pathogenics N-chlorotaurine, or NCT, a novel anti-infective compound for the treatment of eye infections and other diseases.
Pathogenics retains the exclusive worldwide rights to NCT for all indications other than ophthalmic (eye related) applications.
Acuity is paying Pathogenics an up-front licensing fee and minimum annual license fees, as well as milestones and royalties. Further details of the agreement were not disclosed.
Acuity gains worldwide development and commercialization rights to NCT for the treatment of ophthalmic diseases and infections, such as viral conjunctivitis, bacterial conjunctivitis and herpetic keratitis.
Acuity is responsible for clinical development, regulatory activities and commercialization of this compound in ophthalmic indications.
"We are very excited about the broad-spectrum potential of NCT to safely treat ophthalmic diseases and infections," commented Fred Zotos, president and CEO of Pathogenics. "We have every confidence that Acuity Pharmaceuticals will prove itself to be an extremely capable corporate partner in developing NCT as an ophthalmic treatment."
Source: Datamonitor
Related Articles
- Idea to Arm Cancer Patients With Information Specific to Their Disease and Treatment Receives Nod, Grant From American Cancer Society
- Link Medicine Completes $40 Million Series C Financing to Accelerate Development of First Disease-Modifying Treatments for Neurodegenerative Disorders
- Cavit Sciences, Inc. Announces Testing Results of Drug for Cancer and Viral Infection Treatment
- Chronic Diseases Big Killer Worldwide
- Research and Markets: Gain Broader Insight into Current Chronic Obstructive Pulmonary Disease (COPD) Treatment By Consideration of Non-Pharmacological Approaches
- Genes Raise Risk of Heart Disease After Treatment for Childhood Cancer
- Kansas to Test Deer for Disease: Infected Animal Found in State?S Northwest Corner
- Mystery Disease Infects 58, Kills 17 in China's Sichuan Province
- Research and Markets: Future Trends in Treatment of Prostate Cancer and Management of Disease and Treatment Side Effects Revealed
- Women Missing Out on Heart Disease Diagnoses, Treatments
 |
 |
User Comments (0)
RSS Feeds